Biotechnology in Europe - Market Summary, Competitive Analysis and Forecast to 2025
Summary
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The European biotechnology market had total revenues of $105.8bn in 2020, representing a compound annual growth rate (CAGR) of 10.4% between 2016 and 2020.
- The medical/healthcare segment was the market's most lucrative in 2020, with total revenues of $66.7bn, equivalent to 63% of the market's overall value.
- In the wake of the COVID-19 pandemic, which has stalled the global economy and brought unprecedented levels of uncertainty in many sectors, the future of biotechnology is uncertain. Nonetheless, in the mid- to long-term the market as a whole should benefit from rising investment in medicines, as well as government stimulus.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
- What was the size of the Europe biotechnology market by value in 2020?
- What will be the size of the Europe biotechnology market in 2025?
- What factors are affecting the strength of competition in the Europe biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Europe's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of leading players?
- 7.4. What has been the rationale behind recent M&A activity?
- 7.5. Are there any threats to leading players?
- 7.6. Are there any other notable players in the market?
- 7.7. How might the COVID-19 pandemic affect the competitive landscape?
- 8 Company Profiles
- 8.1. F. Hoffmann-La Roche Ltd
- 8.2. Novartis AG
- 8.3. Bayer AG
- 8.4. AstraZeneca PLC
- 8.5. BioNTech SE
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: Europe biotechnology industry value: $ billion, 2016-20
- Table 2: Europe biotechnology industry category segmentation: $ billion, 2020
- Table 3: Europe biotechnology industry geography segmentation: $ billion, 2020
- Table 4: Europe biotechnology industry value forecast: $ billion, 2020-25
- Table 5: F. Hoffmann-La Roche Ltd: key facts
- Table 6: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
- Table 7: F. Hoffmann-La Roche Ltd: Key Employees
- Table 8: Novartis AG: key facts
- Table 9: Novartis AG: Annual Financial Ratios
- Table 10: Novartis AG: Key Employees
- Table 11: Novartis AG: Key Employees Continued
- Table 12: Bayer AG: key facts
- Table 13: Bayer AG: Annual Financial Ratios
- Table 14: Bayer AG: Key Employees
- Table 15: Bayer AG: Key Employees Continued
- Table 16: AstraZeneca PLC: key facts
- Table 17: AstraZeneca PLC: Annual Financial Ratios
- Table 18: AstraZeneca PLC: Key Employees
- Table 19: BioNTech SE: key facts
- Table 20: BioNTech SE: Annual Financial Ratios
- Table 21: BioNTech SE: Key Employees
- Table 22: Europe size of population (million), 2016-20
- Table 23: Europe gdp (constant 2005 prices, $ billion), 2016-20
- Table 24: Europe gdp (current prices, $ billion), 2016-20
- Table 25: Europe inflation, 2016-20
- Table 26: Europe consumer price index (absolute), 2016-20
- Table 27: Europe exchange rate, 2016-20
- List of Figures
- Figure 1: Europe biotechnology industry value: $ billion, 2016-20
- Figure 2: Europe biotechnology industry category segmentation: % share, by value, 2020
- Figure 3: Europe biotechnology industry geography segmentation: % share, by value, 2020
- Figure 4: Europe biotechnology industry value forecast: $ billion, 2020-25
- Figure 5: Forces driving competition in the biotechnology industry in Europe, 2020
- Figure 6: Drivers of buyer power in the biotechnology industry in Europe, 2020
- Figure 7: Drivers of supplier power in the biotechnology industry in Europe, 2020
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Europe, 2020
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Europe, 2020
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in Europe, 2020
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook